湖南裕能(301358.SZ):計劃在西班牙建設年產5萬噸鋰電池正極材料項目
格隆匯6月21日丨湖南裕能(301358.SZ)近日在電話會議中表示,公司計劃在西班牙建設年產5萬噸鋰電池正極材料項目,目前正在籌備項目前期的相關審批工作。近年來,磷酸鐵鋰材料憑藉突出的性價比及安全性能優勢逐漸贏得海外市場的認可。同時,隨着行業技術的不斷創新和迭代,磷酸鐵鋰的性能得到進一步提升,應用領域在不斷拓展,也推動了海外市場對於磷酸鐵鋰正極材料的需求。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.